Mostrar el registro sencillo

dc.contributor.authorChan, Wai Tinges_ES
dc.contributor.authorGarcillán Barcia, María del Pilares_ES
dc.contributor.authorYeo, Chew Chienges_ES
dc.contributor.authorEspinosa, Manueles_ES
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2023-10-31T14:58:22Z
dc.date.available2023-10-31T14:58:22Z
dc.date.issued2023es_ES
dc.identifier.issn0168-6445es_ES
dc.identifier.issn1574-6976es_ES
dc.identifier.otherMCIN/AEI/10.13039/501100011033es_ES
dc.identifier.urihttps://hdl.handle.net/10902/30410
dc.description.abstractToxin-antitoxin (TA) systems are entities found in the prokaryotic genomes, with eight reported types. Type II, the best characterized, is comprised of two genes organized as an operon. Whereas toxins impair growth, the cognate antitoxin neutralizes its activity. TAs appeared to be involved in plasmid maintenance, persistence, virulence, and defence against bacteriophages. Most Type II toxins target the bacterial translational machinery. They seem to be antecessors of Higher Eukaryotes and Prokaryotes Nucleotide-binding (HEPN) RNases, minimal nucleotidyltransferase domains, or CRISPR-Cas systems. A total of four TAs encoded by Streptococcus pneumoniae, RelBE, YefMYoeB, Phd-Doc, and HicAB, belong to HEPN-RNases. The fifth is represented by PezAT/Epsilon-Zeta. PezT/Zeta toxins phosphorylate the peptidoglycan precursors, thereby blocking cell wall synthesis. We explore the body of knowledge (facts) and hypotheses procured for Type II TAs and analyse the data accumulated on the PezAT family. Bioinformatics analyses showed that homologues of PezT/Zeta toxin are abundantly distributed among 14 bacterial phyla mostly in Proteobacteria (48%), Firmicutes (27%), and Actinobacteria (18%), showing the widespread distribution of this TA. The pezAT locus was found to be mainly chromosomally encoded whereas its homologue, the tripartite omega-epsilon-zeta locus, was found mostly on plasmids. We found several orphan pezT/zeta toxins, unaccompanied by a cognate antitoxin.es_ES
dc.description.sponsorshipFunding. This research did not receive specific external funding. However, the laboratories of MPGB and of ME were supported by the Spanish Ministry of Science and Innovation, grants MCIN/AEI/10.13039/501100011033 PID2020-117923GB-I00, and PID2019-104553RB-C21, respectively. CCY was supported by the Malaysian Ministry of Higher Education grant FRGS/1/2019/SKK11/UNISZA/02/1. Acknowledgements. Thanks are due to friends and colleagues for never-ending scientific discussions. Apologies are also due to those colleagues that think they are under cited. We are thankful to Monica Fontenla for the improvements in the quality of the artwork and to Milagros Rodríguez Bueno for help with obtaining a waiver from CSIC. We also acknowledge the support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI), especially to Inmaculada Ramos Hita.es_ES
dc.format.extent21 p.es_ES
dc.language.isoenges_ES
dc.publisherOxford University Presses_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights© The Author(s) 2023es_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceFEMS Microbiology Reviewses_ES
dc.subject.otherBacterial type II toxin–antitoxinses_ES
dc.subject.otherCell wall biosynthesises_ES
dc.subject.otherPathogenicity islandses_ES
dc.subject.otherPneumococcuses_ES
dc.titleType II bacterial toxin-antitoxins: hypotheses, facts, and the newfound plethora of the PezAT systemes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.1093/femsre/fuad052es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1093/femsre/fuad052es_ES
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Attribution-NonCommercial-NoDerivatives 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International